Simple, transparent pricing
Start with Starter.
Scale when ready.
Upgrade when you need more — no long-term contracts, cancel anytime.
"The best ROI decision your lab will make this year."
Frequently asked questions
What is SmartInput™ and how does it improve my document quality? +
SmartInput™ is a three-layer quality intelligence system built into the document studio that evaluates your inputs before generating any document — so you always know the quality of what you are about to receive.
Layer 1 — Word Count Gating: Every question has a calibrated minimum word count. The Generate button stays locked until all fields meet the minimum — preventing thin, vague inputs from producing generic outputs.
Layer 2 — Pre-Flight Quality Score: Before generation, your inputs are scored on 4 dimensions — Specificity, Coherence, Completeness, and Regulatory Context — out of 100. You see a detailed breakdown with specific feedback on exactly what is strong and what is missing. A score of 50 or above unlocks direct generation.
Layer 3 — Dynamic Follow-Up Questions: If your score is below 50, SmartInput™ detects the specific gaps and asks 2 targeted follow-up questions for your exact scenario. Your answers are incorporated into the final document — producing output specific to your actual situation, not a generic template.
What does a SmartInput™ score below 50 mean for my document? +
The SmartInput™ score measures how much useful, specific, scientifically grounded information you have provided. It is not a test — it is a quality signal that shows you exactly what your document will look like before you generate it.
Score 70–100: Strong inputs. Your document will be specific, compliant, and directly relevant to your actual scenario.
Score 50–69: Good inputs. The document will be well-structured and useful. The feedback panel shows what to add next time to reach 70+.
Score 0–49: Thin inputs. The MDS AI does not have enough specific context to produce anything beyond a generic template — and a generic deviation report or CTD module is not useful in a regulated environment. The feedback panel shows in red exactly which fields are causing the low score and what to add. You can still generate — but you are fully informed of the gap before you do.
We set 50 as the threshold because below 50 means the MDS AI is working with less than half the context it needs. Above 50, a useful, specific document will result even if inputs are not perfectly structured.
Why does the studio ask me to write more before I can generate? I thought MDS AI does the work. +
This is the most important question about AI-assisted pharmaceutical documentation — and the answer is the foundation of why Lab AI Document Studio produces audit-ready documents instead of generic ones.
SmartInput™ does not slow you down. It protects you. A QA analyst who spends 3 extra minutes providing specific context receives a deviation investigation report that reflects their actual product, process, and regulatory scenario. An analyst who enters "temperature excursion" and generates receives something that looks like a document but reads like a placeholder.
The word minimums and quality scoring exist because the output quality is directly proportional to the input quality. This studio was built to give you documents that save 3 hours — not documents that save 3 minutes but require 2 hours of rewriting. SmartInput™ is what makes that difference.
Is Lab AI Document Studio compliant for use in GMP-regulated pharmaceutical and biotech environments? +
Yes — compliant by architecture. The studio is designed so you never enter real product data, batch numbers, patient information, or proprietary formulations. Every input uses anonymised placeholder codes. The AI generates complete document structure around your anonymised context, with all placeholders highlighted in yellow for replacement before filing.
Every generated document includes Annexure A — a compliance reference footer citing the exact ICH, WHO GMP, 21 CFR, CDSCO Schedule M, and EU GMP standards the document structure was built against. The studio aligns with FDA guidance (January 2025) and FDA-EMA joint guidance (January 2026) on AI-assisted pharmaceutical documentation. Human review, expert completion of placeholders, and qualified person sign-off remain mandatory before any document enters a QMS or regulatory submission.
Which pharma and lab document types can I generate, and which regulatory standards do they follow? +
The studio covers 50 document types across 5 verticals. Unlocked documents include: Deviation Investigation Report (WHO GMP · ICH Q10 · 21 CFR 211 · ALCOA+ · Schedule M), SOP Generator (WHO GMP · ICH Q10 · ISO 9001), Experimental Protocol (ICH Q1A · Q2(R1) · Q8 · Q14), Literature Review Summary (ICH Q2(R1) · Q3A/B · ICMR), Regulatory Query Response (ICH M4 · FDA Guidance · EMA 726/2004 · CDSCO 2019), CTD Module Draft (ICH M4Q · M4S · M4E), Batch Record Template (ICH Q7 · EU GMP Annex 2 · ALCOA+), Assay Validation Report (ICH Q2(R1) · USP 1225 · FDA 2018 · ISO 17025), Audit Readiness Checklist (WHO GMP · PIC/S · NABL · Schedule M), and Training Needs Assessment (ICH Q10 · WHO GMP · ISO 9001). Premium library documents unlock with Lab Pro and Unlimited plans.
How is Lab AI Document Studio different from using ChatGPT for pharmaceutical documentation? +
Four fundamental differences: 1 — GMP system prompts: Every document type is powered by a purpose-built system prompt embedding deep pharmaceutical regulatory knowledge — ICH guidelines, ALCOA+ principles, CDSCO Schedule M, WHO GMP — into every generation. ChatGPT requires you to explain your regulatory environment every single time. 2 — Compliance annexures: Every document auto-generates Annexure A citing exact standards applied. No general AI tool does this. 3 — SmartInput™ quality scoring: The studio evaluates your inputs before generating. General AI tools accept anything and produce accordingly. 4 — India-first context: CDSCO requirements, Schedule M, Indian Pharmacopoeia, and NABL accreditation are embedded throughout — unavailable in any global AI tool.
What is the ROI of Lab AI Document Studio for a pharmaceutical QC or regulatory affairs team? +
The ROI is measurable from day one. A QA analyst writing a deviation investigation report manually takes 3–4 hours at ₹500/hour — ₹1,500–2,000 of salary cost per document. One document on Lab Pro costs ₹50. ROI on a single document: 30–40x.
A QC team of 5 analysts writing 4 documents each per month generates 20 documents monthly. Lab Pro cost: ₹999/month. Manual documentation cost: ₹30,000–40,000/month. Monthly saving: ₹29,000–39,000. Annual saving per team: ₹3.5–4.5 lakh.
Beyond time savings — the SmartInput™ scoring, compliance annexures, and ALCOA+ alignment reduce the risk of audit observations on documentation quality, which can cost significantly more than the subscription in remediation time and regulatory delays.
Is my confidential pharmaceutical data safe? Does the AI store or train on my inputs? +
Your confidential data is protected by the architecture of the platform itself. The studio is designed so you should never enter confidential data in the first place — you enter anonymised placeholders only. The AI processes only the placeholder-based context you provide in the 4 input fields. This data is used solely to generate your document in real time — it is not stored in our systems, not used to train AI models, and not accessible to any third party. For Enterprise customers requiring data processing agreements or IT security review, contact amit@amitjadhav.com.
Can I cancel my subscription anytime, and what happens to my documents? +
Yes — no long-term contracts, no cancellation fees. Cancel your monthly subscription anytime and you retain full access until the end of your current billing period. Annual plans are non-refundable after 7 days but can be cancelled for the following year at any time. Documents you have already generated and downloaded remain yours — they are stored on your device, not on our servers. You can continue to use and file any documents generated during your subscription period.